SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001613377-17-000021
Filing Date
2017-07-17
Accepted
2017-07-17 15:59:43
Documents
1
Period of Report
2017-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3849
  Complete submission text file 0001613377-17-000021.txt   5251
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 924 EDGEMOOR ROAD CHERRY HILL NJ 08034
Business Address
Pascale Adam (Reporting) CIK: 0001613377 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27072 | Film No.: 17967605